Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 7/2018

01-07-2018 | Editorial

The Conundrum and Challenge of Lung Cancer Screening Shared Decision-making Implementation

Author: Marilyn M. Schapira, MD, MPH

Published in: Journal of General Internal Medicine | Issue 7/2018

Login to get access

Excerpt

In this issue of JGIM, Dr. Wiener and colleagues present findings regarding the implementation of shared decision-making (SDM) for lung cancer screening among health care systems that were early adopters.1 The study methods were elegantly designed to provide parallel perspectives from the clinician and patient regarding key aspects of the SDM construct: information sharing, deliberation, and use of decision aids. The parallel process of data collection and analysis provides an opportunity to compare and contrast perspectives. …
Literature
1.
2.
Moyer VA, Force USPST. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-8.PubMed
3.
4.
National Lung Screening Trial Research T, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395–409.CrossRef
5.
Ripping TM, Ten Haaf K, Verbeek ALM, van Ravesteyn NT, Broeders MJM. Quantifying Overdiagnosis in Cancer Screening: A Systematic Review to Evaluate the Methodology. J Natl Cancer Inst 2017;109.
6.
Marcus PM, Prorok PC, Miller AB, DeVoto EJ, Kramer BS. Conceptualizing overdiagnosis in cancer screening. J Natl Cancer Inst 2015;107CrossRef
7.
McCaffery KJ, Jansen J, Scherer LD, et al. Walking the tightrope: communicating overdiagnosis in modern healthcare. BMJ 2016;352:i348.CrossRef
8.
Trivedi RB, Post EP, Sun H, et al. Prevalence, Comorbidity, and Prognosis of Mental Health Among US Veterans. Am J Public Health 2015;105:2564–9.CrossRef
9.
Lempert KM, Phleps EA. The Malleability of Intertemporal Choice. Trends Cogn Sci 20 (1):64–74, 2016CrossRef
10.
Siu AL, Force USPST. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2016;164:279–9CrossRef
Metadata
Title
The Conundrum and Challenge of Lung Cancer Screening Shared Decision-making Implementation
Author
Marilyn M. Schapira, MD, MPH
Publication date
01-07-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 7/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4449-z

Other articles of this Issue 7/2018

Journal of General Internal Medicine 7/2018 Go to the issue

Original Research

The Impact of Automated Notification on Follow-up of Actionable Tests Pending at Discharge: a Cluster-Randomized Controlled Trial

OriginalPaper

Factors of U.S. Hospitals Associated with Improved Profit Margins: An Observational Study

OriginalPaper

The Impact of Off-Patent Drug Acquisitions on Prices

Concise Research Reports

Terry’s Nails: Clinical Correlations in Adult Outpatients

Original Research

Racial and Ethnic Disparities in Diagnosis of Chronic Medical Conditions in the USA

Capsule Commentary

Capsule Commentary on Dalal et al., The Impact of Automated Notification on Follow-up of Actionable Tests Pending at Discharge: a Cluster-Randomized Controlled Trial
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits